Literature DB >> 19522018

Role of scintigraphy in inflammatory bowel disease.

Maria I Stathaki, Sophia I Koukouraki, Nikolaos S Karkavitsas, Ioannis E Koutroubakis.   

Abstract

The diagnosis of inflammatory bowel disease (IBD) depends on direct endoscopic visualization of the colonic and ileal mucosa and the histological study of the obtained samples. Radiological and scintigraphic methods are mainly used as an adjunct to endoscopy. In this review, we focus on the diagnostic potential of nuclear medicine procedures. The value of all radiotracers is described with special reference to those with greater experience and more satisfactory results. Tc-99m hexamethylpropylene amine oxime white blood cells remain a widely acceptable scintigraphic method for the diagnosis of IBD, as well as for the evaluation of disease extension and severity. Recently, pentavalent Tc-99m dimercaptosuccinic acid has been recommended as an accurate variant and a complementary technique to endoscopy for the follow-up and assessment of disease activity. Positron emission tomography alone or with computed tomography using fluorine-18 fluorodeoxyglucose appears to be a promising method of measuring inflammation in IBD patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19522018      PMCID: PMC2695883          DOI: 10.3748/wjg.15.2693

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  67 in total

Review 1.  Clinical applications of radiolabeled blood elements in inflammatory bowel disease.

Authors:  J Martin-Comin; E Prats
Journal:  Q J Nucl Med       Date:  1999-03

2.  (99m)Tc antigranulocyte monoclonal antibody imaging for the detection and assessment of inflammatory bowel disease newly diagnosed by colonoscopy in children.

Authors:  M Charron; C Di Lorenzo; S A Kocoshis; M P Hickeson; S R Orenstein; A Goyal; S Kahn; L Collins
Journal:  Pediatr Radiol       Date:  2001-11

Review 3.  Imaging inflammatory bowel disease using bowel ultrasound.

Authors:  Fabrizio Parente; Salvatore Greco; Mirko Molteni; Andrea Anderloni; Gabriele Bianchi Porro
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-03       Impact factor: 2.566

4.  Technetium-99m(V)-DMSA and gallium-67 in the assessment of bone and joint infection.

Authors:  B F Lee; N T Chiu; J K Chang; G C Liu; H S Yu
Journal:  J Nucl Med       Date:  1998-12       Impact factor: 10.057

5.  CT and 99mTc-WBC vs colonoscopy in the evaluation of inflammation and complications of inflammatory bowel diseases.

Authors:  Martin Charron; Carlo Di Lorenzo; Samuel Kocoshis
Journal:  J Gastroenterol       Date:  2002-01       Impact factor: 7.527

6.  Inflammatory bowel disease evaluated by low-field magnetic resonance imaging. Comparison with endoscopy, 99mTc-HMPAO leucocyte scintigraphy, conventional radiography and surgery.

Authors:  S M Madsen; H S Thomsen; P Munkholm; B Davidsen; S Dorph; S Levin Nielsen; P Schlichting
Journal:  Scand J Gastroenterol       Date:  2002-03       Impact factor: 2.423

7.  Technetium-99m-HMPAO labeled leukocyte single photon emission computerized tomography (SPECT) for assessing Crohn's disease extent and intestinal infiltration.

Authors:  L Biancone; O Schillaci; F Capoccetti; R M Bozzi; D Fina; C Petruzziello; A Geremia; G Simonetti; F Pallone
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

8.  Pediatric inflammatory bowel disease: assessment with scintigraphy with 99mTc white blood cells.

Authors:  M Charron; F J del Rosario; S A Kocoshis
Journal:  Radiology       Date:  1999-08       Impact factor: 11.105

9.  Concordance between abdominal scintigraphy using technetium-99m hexamethylpropylene amine oxime-labelled leucocytes and ileocolonoscopy in patients with spondyloarthropathies and without clinical evidence of inflammatory bowel disease.

Authors:  A El Maghraoui; M Dougados; E Freneaux; S Chaussade; B Amor; M Breban
Journal:  Rheumatology (Oxford)       Date:  1999-06       Impact factor: 7.580

10.  Technetium-99m-HMPAO-labeled leukocyte imaging in patients with seronegative spondyloarthropathies.

Authors:  J C Alonso; A Soriano; C Rubio; J L Cuadra; M Zarca; P Guerra; A Garcia; C Molino
Journal:  J Nucl Med Technol       Date:  1999-09
View more
  5 in total

1.  Leukocyte-technetium-99m uptake in Crohn's disease: does it show subclinical disease?

Authors:  Luciene G Mota; Luiz G V Coelho; Carlos J R Simal; Maria L A Ferrari; Clodomiro Toledo; Josep Martin-Comin; Simone O F Diniz; Valbert N Cardoso
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

2.  Small bowel imaging of inflammatory bowel disease.

Authors:  Emanuele Casciani; Chiara De Vincentiis; Gianfranco Gualdi
Journal:  World J Radiol       Date:  2015-08-28

3.  Toward Molecular Imaging of Intestinal Pathology.

Authors:  Mariane Le Fur; Iris Y Zhou; Onofrio Catalano; Peter Caravan
Journal:  Inflamm Bowel Dis       Date:  2020-09-18       Impact factor: 5.325

Review 4.  Radiographical evaluation of ulcerative colitis.

Authors:  Parakkal Deepak; David H Bruining
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-05-19

5.  Accuracy of 99mTc (V)-Dimercaptosuccinic Acid Scintigraphy and Fecal Calprotectin Compared with Colonoscopy in Localizing Active Lesions in Inflammatory Bowel Disease.

Authors:  Vahid Basirat; Zahra Azizi; Sanam Javid Anbardan; Mina Taghizadeh Asl; Yasaman Farbod; Azam Teimouri; Nasser Ebrahimi Daryani
Journal:  Middle East J Dig Dis       Date:  2016-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.